Minerva Neurosciences, Inc. Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss
Minerva Neurosciences, Inc. (NERV) had Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss of $62.12 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss · last filed 2026-08-07
- 2026-06-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $62.12K.
- 2026-03-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $76.55K.
- 2019-12-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $1.19K.
- 2019-09-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss $2.54K.
| Period end | Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss |
|---|---|
| 2026-06-30 | $62.12K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $76.55K 10-Q · filed 2026-05-05 |
| 2019-12-31 | $1.19K 10-K · filed 2021-03-08 |
| 2019-09-30 | $2.54K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $11.44K 10-Q · filed 2019-08-05 |
| 2019-03-31 | $11.61K 10-Q · filed 2019-05-06 |
| 2017-09-30 | $38.95K 10-Q · filed 2017-11-06 |
| 2016-06-30 | $3.14K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $7.56K 10-Q · filed 2016-05-03 |
| 2015-12-31 | $33.07K 10-K · filed 2016-03-14 |
| 2015-09-30 | $24.78K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $50.00K 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |